Biernacki M et al. |
Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma. |
2018 |
Prostaglandins Other Lipid Mediat. |
pmid:30201316
|
DeVuono MV et al. |
Conditioned gaping produced by high dose Δ-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system. |
2018 |
Neuropharmacology |
pmid:30195587
|
Covey DP et al. |
Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease. |
2018 |
Neuropsychopharmacology |
pmid:29925886
|
Morena M et al. |
Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats. |
2018 |
Neuropsychopharmacology |
pmid:29265107
|
Eroli F et al. |
Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing. |
2018 |
Neuropharmacology |
pmid:29225040
|
Sepers MD et al. |
Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model. |
2018 |
J. Neurosci. |
pmid:29192125
|
Signorello MG and Leoncini G |
Activation of CaMKKβ/AMPKα pathway by 2-AG in human platelets. |
2018 |
J. Cell. Biochem. |
pmid:28661046
|
Szafran BN et al. |
Characterization of Endocannabinoid-Metabolizing Enzymes in Human Peripheral Blood Mononuclear Cells under Inflammatory Conditions. |
2018 |
Molecules |
pmid:30513753
|
Iannotti FA et al. |
Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy. |
2018 |
Nat Commun |
pmid:30262909
|
Chicca A et al. |
Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake. |
2017 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:28584105
|
Becker TM et al. |
Endocannabinoid-dependent disinhibition of orexinergic neurons: Electrophysiological evidence in leptin-knockout obese mice. |
2017 |
Mol Metab |
pmid:28580289
|
Fanelli F et al. |
Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women. |
2017 |
Mol Metab |
pmid:28462075
|
Bedse G et al. |
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety. |
2017 |
Biol. Psychiatry |
pmid:28438413
|
Pasquarelli N et al. |
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS. |
2017 |
Neuropharmacology |
pmid:28373073
|
Bluett RJ et al. |
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. |
2017 |
Nat Commun |
pmid:28348378
|
Forner-Piquer I et al. |
Dose-Specific Effects of Di-Isononyl Phthalate on the Endocannabinoid System and on Liver of Female Zebrafish. |
2017 |
Endocrinology |
pmid:28938452
|
Martin GG et al. |
Endocannabinoid Interaction with Human FABP1: Impact of the T94A Variant. |
2017 |
Biochemistry |
pmid:28853554
|
Granchi C et al. |
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017). |
2017 |
Expert Opin Ther Pat |
pmid:29053063
|
Leonard MZ et al. |
Cannabinoid CB Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors. |
2017 |
J. Pharmacol. Exp. Ther. |
pmid:28947487
|
Feliú A et al. |
2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination. |
2017 |
J. Neurosci. |
pmid:28751457
|